 | Your browser does not display parts of our website correctly. We use the latest technology available to provide you with a high quality experience; please upgrade your browser to its latest version to view the contents properly: |
Cross Country Healthcare, Inc. (CCRN) provides talent management and other consultative services for healthcare clients in the United States.
The company operates in two segments, Nurse and Allied Staffing and Physician Staffing. 
The Nurse and Allied Staffing segment offers traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, local nurses, and allied staffing; staffing solutions for registered nurses, licensed practical nurses, certified nurse assistants, practitioners, pharmacists, and other allied professionals on per diem and short-term assignments; and clinical and non-clinical professionals on long-term contract assignments, as well as workforce solutions, including MSP, RPO, and consulting services.
This segment serves public and private acute care and non-acute care hospitals, government facilities, local and national healthcare plans, managed care providers, public and charter schools, outpatient clinics, ambulatory care facilities, physician practice groups, and other healthcare providers under the Cross Country brand.
The Physician Staffing segment provides physicians in various specialties, certified registered nurse anesthetists, nurse practitioners, and physician assistants under the Cross Country Locums brand as independent contractors on temporary assignments at various healthcare facilities, such as acute and non-acute care facilities, medical group practices, government facilities, and managed care organizations.
On August 3rd, CCRN reported 2nd Quarter June 2022 earnings of $1.40 per share on revenue of $753.6 million. The consensus earnings estimate was $1.35 per share on revenue of $741.1 million. Revenue grew 127.1% on a year-over-year basis. The next report is on November 2.
Shares are heading higher in an upward trading channel. Higher share prices are expected.
Entry Point: $32.25
Trading Range: $15.26 to $34.98
Stop Loss: $30.50
Target Price: $35.50
